{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:42:38Z","timestamp":1778272958093,"version":"3.51.4"},"reference-count":113,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,2,1]]},"abstract":"<jats:p>ANCA (anti-neutrophil cytoplasm antibody)-associated small vessel vasculitis is an inflammatory condition associated with the production of autoantibodies to neutrophil cytoplasmic components. The disorder results in destruction of the microvasculature, infiltration of neutrophils into tissues, which is followed later by mononuclear cells, leading to injury and the formation of granulomatous lesions. Initiators for the disease are undetermined but a pro-inflammatory environment is required. Other influencing factors may include environmental triggers, genetic propensity or infectious agents. The primary cellular event in the condition involves the neutrophils, which are likely to be responsible for the majority of tissue injury. Binding of the autoantibody to neutrophils initiates cell activation via a complex intracellular signalling cascade, culminating in the release of pro-inflammatory mediators, proteolytic enzymes and reactive oxygen species. Adhesion of neutrophils to endothelial cells is observed in vitro and more investigations in this area may explain the focussing of the disease to certain vessels\/tissues. Current treatment regimens have substantial toxicity. Although newer developments are an improvement there is still a pressing need for more targeted therapies, which could be provided by extrapolating information emerging from basic scientific research.<\/jats:p>","DOI":"10.1042\/cs20040232","type":"journal-article","created":{"date-parts":[[2005,1,21]],"date-time":"2005-01-21T11:23:30Z","timestamp":1106306610000},"page":"101-112","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Translating basic science into patient therapy for ANCA-associated small vessel vasculitis"],"prefix":"10.1042","volume":"108","author":[{"given":"Julie\u00a0M.","family":"WILLIAMS","sequence":"first","affiliation":[{"name":"Renal Immunobiology, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"KAMESH","sequence":"additional","affiliation":[{"name":"Renal Immunobiology, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline\u00a0O.\u00a0S.","family":"SAVAGE","sequence":"additional","affiliation":[{"name":"Renal Immunobiology, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2005,1,21]]},"reference":[{"key":"2021120120345800100_B1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(97)80118-3","article-title":"Primary systemic vasculitis","volume":"349","author":"Savage","year":"1997","journal-title":"Lancet"},{"key":"2021120120345800100_B2","doi-asserted-by":"crossref","first-page":"SII100","DOI":"10.3949\/ccjm.69.Suppl_2.SII100","article-title":"Measuring disease activity and outcomes in clinical studies","volume":"69","author":"Luqmani","year":"2002","journal-title":"Cleveland Clin. J. Med."},{"key":"2021120120345800100_B3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002281-200201000-00005","article-title":"Assessing disease activity in the systemic vasculitides","volume":"14","author":"Luqmani","year":"2002","journal-title":"Curr. Opin. Rheumatol."},{"key":"2021120120345800100_B4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jcp.50.8.677","article-title":"Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence","volume":"50","author":"Yang","year":"1997","journal-title":"J. Clin. Pathol."},{"key":"2021120120345800100_B5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1523-1755.2003.00821.x","article-title":"Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis","volume":"63","author":"Han","year":"2003","journal-title":"Kidney Int."},{"key":"2021120120345800100_B6","doi-asserted-by":"crossref","first-page":"SII33","DOI":"10.3949\/ccjm.69.Suppl_2.SII33","article-title":"Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis","volume":"69","author":"Jennette","year":"2002","journal-title":"Cleveland Clin. J. Med."},{"key":"2021120120345800100_B7","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1152\/ajprenal.00008.2002","article-title":"Circulating endothelial cells: tea leaves for renal disease","volume":"283","author":"Segal","year":"2002","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021120120345800100_B8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11926-004-0067-3","article-title":"Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis","volume":"6","author":"Cid","year":"2004","journal-title":"Curr. Rheumatol. Rep."},{"key":"2021120120345800100_B9","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/ndt\/13.7.1662","article-title":"Cytokines and adhesion molecules in renal vasculitis and lupus nephritis","volume":"13","author":"Tesar","year":"1998","journal-title":"Nephrol., Dial., Transplant."},{"key":"2021120120345800100_B10","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1189\/jlb.71.6.996","article-title":"Wegner's granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release: role of autocrine activation","volume":"71","author":"Hattar","year":"2002","journal-title":"J. Leukocyte Biol."},{"key":"2021120120345800100_B11","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1046\/j.1523-1755.1999.055003852.x","article-title":"Interleukin-8: a pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis","volume":"55","author":"Cockwell","year":"1999","journal-title":"Kidney Int."},{"key":"2021120120345800100_B12","first-page":"BR24","article-title":"Soluble cytokine receptors in renal vasculitis and lupus nephritis","volume":"8","author":"Tesar","year":"2002","journal-title":"Med. Sci. Monit."},{"key":"2021120120345800100_B13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ndt\/16.2.276","article-title":"Circulating soluble adhesion molecules in ANCA-associated vasculitis","volume":"16","author":"Ara","year":"2001","journal-title":"Nephrol., Dial., Transplant."},{"key":"2021120120345800100_B14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1189\/jlb.1202611","article-title":"Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies","volume":"74","author":"Rarok","year":"2003","journal-title":"J. Leukocyte Biol."},{"key":"2021120120345800100_B15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1084\/jem.177.4.905","article-title":"Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model","volume":"177","author":"Brouwer","year":"1993","journal-title":"J. Exp. Med."},{"key":"2021120120345800100_B16","first-page":"1695","article-title":"Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat","volume":"149","author":"Heeringa","year":"1996","journal-title":"Am. J. Pathol."},{"key":"2021120120345800100_B17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.1995.58","article-title":"Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies","volume":"47","author":"Kobayashi","year":"1995","journal-title":"Kidney Int."},{"key":"2021120120345800100_B18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2021120120345800100_B19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1006667703202","article-title":"Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases","volume":"20","author":"Chikazawa","year":"2000","journal-title":"J. Clin. Immunol."},{"key":"2021120120345800100_B20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2249.2001.01420.x","article-title":"Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site","volume":"123","author":"Griffith","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B21"},{"key":"2021120120345800100_B22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)91761-A","article-title":"Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy","volume":"342","author":"Dolman","year":"1993","journal-title":"Lancet"},{"key":"2021120120345800100_B23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/oxfordjournals.ndt.a027846","article-title":"Case of propylthiouracil-induced ANCA associated small vessel vasculitis","volume":"13","author":"Harper","year":"1998","journal-title":"Nephrol., Dial., Transplant."},{"key":"2021120120345800100_B24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.2004.02029.x","article-title":"Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease: the importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis case of propylthiouracil-induced ANCA associated small vessel vasculitis","volume":"60","author":"Harper","year":"2004","journal-title":"Clin. Endocrinol. (Oxford)"},{"key":"2021120120345800100_B25","first-page":"4270","article-title":"High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil","volume":"85","author":"Sato","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021120120345800100_B26","first-page":"354","article-title":"Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis","volume":"19","author":"Waldhauser","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"2021120120345800100_B27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clin.1996.0110","article-title":"T cells ignore the parent drug propylthiouracil but are sensitized to a reactive metabolite generated in vivo","volume":"80","author":"von\u00a0Schmiedeberg","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"key":"2021120120345800100_B28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.55.10.769","article-title":"Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA","volume":"55","author":"Elkayam","year":"1996","journal-title":"Ann. Rheum. Dis."},{"key":"2021120120345800100_B29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","article-title":"Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum."},{"key":"2021120120345800100_B30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/ndt\/9.5.559","article-title":"Wegener's granulomatosis associated with silicosis","volume":"9","author":"Neyer","year":"1994","journal-title":"Nephrol., Dial., Transplant."},{"key":"2021120120345800100_B31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V121134","article-title":"Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis","volume":"12","author":"Hogan","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021120120345800100_B32","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/art.10830","article-title":"Are environmental factors important in primary systemic vasculitis? A case-control study","volume":"48","author":"Lane","year":"2003","journal-title":"Arthritis Rheum."},{"key":"2021120120345800100_B33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tox.2003.09.011","article-title":"Silica-exposed mice generate autoantibodies to apoptotic cells","volume":"195","author":"Pfau","year":"2004","journal-title":"Toxicology"},{"key":"2021120120345800100_B34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"2021120120345800100_B35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch co-trimoxazole Wegener study group","volume":"335","author":"Stegeman","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"2021120120345800100_B36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1365-2249.2000.01172.x","article-title":"Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?","volume":"119","author":"Brons","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(05)70238-6","article-title":"Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?","volume":"27","author":"Brons","year":"2001","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"2021120120345800100_B38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/ard.60.12.1097","article-title":"Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis","volume":"60","author":"Brons","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"2021120120345800100_B39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/03009748809098787","article-title":"Wegener's granulomatosis in a family. A short report","volume":"17","author":"Knudsen","year":"1988","journal-title":"Scand. J. Rheumatol."},{"key":"2021120120345800100_B40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S0022215100115129","article-title":"Wegener's granulomatosis in two siblings: a family study","volume":"105","author":"Stoney","year":"1991","journal-title":"J. Laryngol. Otol."},{"key":"2021120120345800100_B41","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/ki.1992.161","article-title":"HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens","volume":"41","author":"Spencer","year":"1992","journal-title":"Kidney Int."},{"key":"2021120120345800100_B42","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-122-8-199504150-00029","article-title":"HLA typing in patients with Wegener granulomatosis","volume":"122","author":"Cotch","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"2021120120345800100_B43","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ki.1995.353","article-title":"Decreased frequency of HLA-DR13DR6 in Wegener's granulomatosis","volume":"48","author":"Hagen","year":"1995","journal-title":"Kidney Int."},{"key":"2021120120345800100_B44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2249.1999.00969.x","article-title":"Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis","volume":"117","author":"Gencik","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B45","first-page":"1534","article-title":"Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis","volume":"30","author":"Tsuchiya","year":"2003","journal-title":"J. Rheumatol."},{"key":"2021120120345800100_B46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ki.1993.186","article-title":"\u03b11-Antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis","volume":"43","author":"Esnault","year":"1993","journal-title":"Kidney Int."},{"key":"2021120120345800100_B47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2796.1994.tb00842.x","article-title":"Strong link between the \u03b11-antitrypsin PiZ allele and Wegener's granulomatosis","volume":"236","author":"Elzouki","year":"1994","journal-title":"J. Intern. Med."},{"key":"2021120120345800100_B48","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ki.1995.360","article-title":"The PiZ gene of \u03b11-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis","volume":"48","author":"Segelmark","year":"1995","journal-title":"Kidney Int."},{"key":"2021120120345800100_B49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/ndt\/12.2.249","article-title":"ANCA-positive vasculitis and \u03b11-antitrypsin deficiency: could free ANCA antigens released by neutrophils mediate vasculitic lesions?","volume":"12","author":"Esnault","year":"1997","journal-title":"Nephrol., Dial., Transplant."},{"key":"2021120120345800100_B50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/clim.2000.4962","article-title":"A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis","volume":"98","author":"Borgmann","year":"2001","journal-title":"Clin. Immunol."},{"key":"2021120120345800100_B51","first-page":"S35","article-title":"New developments in the pathogenesis of ANCA-associated vasculitis","volume":"21","author":"Day","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"2021120120345800100_B52","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood.V94.7.2487.419k07_2487_2496","article-title":"Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules","volume":"94","author":"Witko-Sarsat","year":"1999","journal-title":"Blood"},{"key":"2021120120345800100_B53","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1097\/01.ASN.0000028642.26222.00","article-title":"Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis","volume":"13","author":"Rarok","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021120120345800100_B54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.ASN.0000040751.83734.D1","article-title":"Membrane expression of proteinase 3 is genetically determined","volume":"14","author":"Schreiber","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021120120345800100_B55","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1046\/j.1523-1755.2000.00430.x","article-title":"Proteinase 3 gene polymorphisms and Wegener's granulomatosis the association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis","volume":"58","author":"Gencik","year":"2000","journal-title":"Kidney Int."},{"key":"2021120120345800100_B56","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-1759(94)90364-6","article-title":"Measurements of proteinase 3 and its complexes with \u03b11-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma","volume":"175","author":"Baslund","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"2021120120345800100_B57","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/art.1780370116","article-title":"Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa","volume":"37","author":"Henshaw","year":"1994","journal-title":"Arthritis Rheum."},{"key":"2021120120345800100_B58","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2249.2003.02083.x","article-title":"Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission","volume":"131","author":"Ohlsson","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B59","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.153.3.1271","article-title":"Anti-neutrophil cytoplasmaic antibodies engage and activate human neutrophils via fc\u03b3riia","volume":"153","author":"Porges","year":"1994","journal-title":"J. Immunol."},{"key":"2021120120345800100_B60","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/eji.1830210820","article-title":"A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor ii on human monocytes","volume":"21","author":"Clark","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"2021120120345800100_B61","first-page":"476","article-title":"IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis","volume":"84","author":"Jayne","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B62","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2249.1999.00960.x","article-title":"No association between neutrophil Fc\u03b3riia allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis","volume":"117","author":"Tse","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B63","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/1529-0131(199909)42:9<1823::AID-ANR5>3.0.CO;2-X","article-title":"Fc\u03b3 receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse","volume":"42","author":"Dijstelbloem","year":"1999","journal-title":"Arthritis Rheum."},{"key":"2021120120345800100_B64","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/1529-0131(200006)43:6<1337::AID-ANR16>3.0.CO;2-M","article-title":"Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion","volume":"43","author":"Radford","year":"2000","journal-title":"Arthritis Rheum."},{"key":"2021120120345800100_B65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/clim.1999.4811","article-title":"The association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides","volume":"94","author":"Gencik","year":"2000","journal-title":"Clin. Immunol."},{"key":"2021120120345800100_B66","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2249.1999.00889.x","article-title":"C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis","volume":"116","author":"Persson","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B67","first-page":"226","article-title":"Polymorphisms in the tumor necrosis factor genes in Wegener's granulomatosis","volume":"14","author":"Mascher","year":"1997","journal-title":"Exp. Clin. Immunogenet."},{"key":"2021120120345800100_B68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1399-0039.1997.tb02812.x","article-title":"Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus","volume":"49","author":"Eskdale","year":"1997","journal-title":"Tissue Antigens."},{"key":"2021120120345800100_B69","first-page":"317","article-title":"Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene","volume":"29","author":"Zhou","year":"2002","journal-title":"J. Rheumatol."},{"key":"2021120120345800100_B70","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00439-004-1092-z","article-title":"New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes","volume":"114","author":"Jagiello","year":"2004","journal-title":"Hum. Genet."},{"key":"2021120120345800100_B71","first-page":"397","article-title":"Polymorphisms in CTLA-4 but not tumor necrosis factor-\u03b1 or interleukin 1\u03b2 genes are associated with Wegener's granulomatosis","volume":"27","author":"Huang","year":"2000","journal-title":"J. Rheumatol."},{"key":"2021120120345800100_B72","first-page":"950","article-title":"Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis polymorphisms in CTLA-4 but not tumor necrosis factor-\u03b1 or interleukin 1\u03b2 genes are associated with Wegener's granulomatosis","volume":"29","author":"Giscombe","year":"2002","journal-title":"J. Rheumatol."},{"key":"2021120120345800100_B73","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1365-2249.2003.02280.x","article-title":"Involvement of Fc\u03b3 receptors and \u03b22 integrins in neutrophil activation by anti-proteinase-3 or anti-myeloperoxidase antibodies","volume":"134","author":"Reumaux","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B74","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1189\/jlb.1202624","article-title":"Interaction of proteinase 3 with CD11b\/CD18 (\u03b22 integrin) on the cell membrane of human neutrophils","volume":"74","author":"David","year":"2003","journal-title":"J. Leukocyte Biol."},{"key":"2021120120345800100_B75","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1074\/jbc.M309778200","article-title":"Integrins and cytokines activate nuclear transcription factor-\u03baB in human neutrophils","volume":"279","author":"Kettritz","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021120120345800100_B76","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.ASN.0000050223.34749.F4","article-title":"Activation of the Gi heterotrimeric G protein by ANCA IgG f(ab\u2032)2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG","volume":"14","author":"Williams","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021120120345800100_B77","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/01.ASN.0000113241.98702.77","article-title":"Activation of Syk in neutrophils by antineutrophil cytoplasm antibodies occurs via Fc\u03b3 receptors and CD18","volume":"15","author":"Hewins","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021120120345800100_B78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2249.1999.01043.x","article-title":"The activation of the neutrophil respiratory burst by anti-neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activation","volume":"118","author":"Radford","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B79","first-page":"152","article-title":"Effect of anti-neutrophil cytoplasm autoantibodies on the intracellular calcium concentration of human neutrophils","volume":"70","author":"Lai","year":"1994","journal-title":"Lab. Invest."},{"key":"2021120120345800100_B80","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood.V98.5.1448","article-title":"Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fc\u03b3 receptor ligation","volume":"98","author":"Ben-Smith","year":"2001","journal-title":"Blood"},{"key":"2021120120345800100_B81","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1046\/j.1523-1755.2001.0590051729.x","article-title":"Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis","volume":"59","author":"Harper","year":"2001","journal-title":"Kidney Int."},{"key":"2021120120345800100_B82","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9440(10)64532-4","article-title":"Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages","volume":"157","author":"Harper","year":"2000","journal-title":"Am. J. Pathol."},{"key":"2021120120345800100_B83","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1681\/ASN.V1191639","article-title":"Upregulation of CD14 and CD18 on monocytes in vitro by antineutrophil cytoplasmic autoantibodies","volume":"11","author":"Nowack","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021120120345800100_B84","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-3083.1998.00348.x","article-title":"Effect of anti-neutrophil cytoplasmic antibodies on proteinase 3-induced apoptosis of human endothelial cells","volume":"48","author":"Taekema-Roelvink","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"2021120120345800100_B84a","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1189\/jlb.0104054","article-title":"ANCA induces \u03b22 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium","volume":"77","author":"Calderwood","year":"2005","journal-title":"J. Leukocyte Biol."},{"key":"2021120120345800100_B85","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/clin.1994.1007","article-title":"IgG subclass distribution and complement activation ability of autoantibodies to neutrophil cytoplasmic antigens (ANCA)","volume":"70","author":"Mellbye","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"2021120120345800100_B86","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780350914","article-title":"Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity","volume":"35","author":"Schmitt","year":"1992","journal-title":"Arthritis Rheum."},{"key":"2021120120345800100_B87","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF01451285","article-title":"Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systematic vasculitis and microvascular capillaroscopic abnormalities","volume":"17","author":"Kuryliszyn-Moskal","year":"1998","journal-title":"Clin. Rheumatol."},{"key":"2021120120345800100_B88","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1994.tb05511.x","article-title":"T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG)","volume":"98","author":"Brouwer","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B89","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2249.1996.d01-629.x","article-title":"T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis","volume":"103","author":"Griffith","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B90","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2249.1998.00615.x","article-title":"T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission","volume":"112","author":"King","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B91","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2249.2000.01415.x","article-title":"In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)","volume":"122","author":"van\u00a0der\u00a0Geld","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B92","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","article-title":"Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation","volume":"42","author":"Csernok","year":"1999","journal-title":"Arthritis Rheum."},{"key":"2021120120345800100_B93","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.4049\/jimmunol.160.7.3602","article-title":"Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10","volume":"160","author":"Ludviksson","year":"1998","journal-title":"J. Immunol."},{"key":"2021120120345800100_B94","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1365-2249.2001.125002332.x","article-title":"Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis","volume":"125","author":"Balding","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B95","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1023\/A:1023230722874","article-title":"Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity","volume":"18","author":"Giscombe","year":"1998","journal-title":"J. Clin. Immunol."},{"key":"2021120120345800100_B96","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0002-9440(10)61118-2","article-title":"Peripheral blood and granuloma CD4+CD28\u2212 T cells are a major source of interferon-\u03b3 and tumor necrosis factor-\u03b1 in Wegener's granulomatosis","volume":"160","author":"Komocsi","year":"2002","journal-title":"Am. J. Pathol."},{"key":"2021120120345800100_B97","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2249.2001.01575.x","article-title":"Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis","volume":"126","author":"Steiner","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"2021120120345800100_B98","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1046\/j.1523-1755.2002.00619.x","article-title":"Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA)","volume":"62","author":"Yang","year":"2002","journal-title":"Kidney Int."},{"key":"2021120120345800100_B99","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000072990","article-title":"Current attitudes to the therapy of vasculitis","volume":"26","author":"Jayne","year":"2003","journal-title":"Kidney Blood Press. Res."},{"key":"2021120120345800100_B100","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","article-title":"Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy","volume":"44","author":"Specks","year":"2001","journal-title":"Arthritis Rheum."},{"key":"2021120120345800100_B101","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000072991","article-title":"Current status of tumor necrosis factor inhibition strategies in the treatment of vasculitis","volume":"26","author":"Stone","year":"2003","journal-title":"Kidney Blood Press. Res."},{"key":"2021120120345800100_B102","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00001622-200011000-00011","article-title":"Role of tumor necrosis factor-\u03b1 inhibition with infliximab in cancer therapy and hematopoietic stem cell transplantation","volume":"12","author":"Couriel","year":"2000","journal-title":"Curr. Opin. Oncol."},{"key":"2021120120345800100_B103","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0196-9781(03)00083-4","article-title":"Targeting ICAM-1\/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors","volume":"24","author":"Anderson","year":"2003","journal-title":"Peptides"},{"key":"2021120120345800100_B104","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10001","article-title":"Inhibition of LFA-1\/ICAM-1 and VLA-4\/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases","volume":"22","author":"Yusuf-Makagiansar","year":"2002","journal-title":"Med. Res. Rev."},{"key":"2021120120345800100_B105","doi-asserted-by":"crossref","first-page":"15895","DOI":"10.1073\/pnas.2631433100","article-title":"Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo","volume":"100","author":"Sakhalkar","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021120120345800100_B106","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/bjo.88.1.145","article-title":"Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research","volume":"88","author":"Donnelly","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"2021120120345800100_B107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(01)00385-X","article-title":"The Ras-pathway inhibitor, S-trans-trans-farnesyl-thiosalicylic acid, suppresses experimental allergic encephalomyelitis","volume":"120","author":"Karussis","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"2021120120345800100_B108","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2174\/1381612043384493","article-title":"The spleen tyrosine kinase (Syk) in human disease, implications for design of tyrosine kinase inhibitor based therapy","volume":"10","author":"Navara","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"2021120120345800100_B109","first-page":"222","article-title":"Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors","volume":"2","author":"Prud'homme","year":"2000","journal-title":"J. Genet. Med."},{"key":"2021120120345800100_B110","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2567.2004.01875.x","article-title":"Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen","volume":"112","author":"Reiners","year":"2004","journal-title":"Immunology"},{"key":"2021120120345800100_B111","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/art.11168","article-title":"Polymorphism at position \u2212308 of the tumor necrosis factor \u03b1 gene influences outcome of infliximab therapy in rheumatoid arthritis","volume":"48","author":"Mugnier","year":"2003","journal-title":"Arthritis Rheum."},{"key":"2021120120345800100_B112","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-200403000-00006","article-title":"Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)","volume":"14","author":"Marinaki","year":"2004","journal-title":"Pharmacogenetics"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/108\/2\/101\/435927\/cs1080101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/108\/2\/101\/435927\/cs1080101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T19:13:03Z","timestamp":1682968383000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/108\/2\/101\/67918\/Translating-basic-science-into-patient-therapy-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,21]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20040232","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,21]]}}}